Newswise — Washington, DC—Diabetes experts, policymakers and patient advocates will gather to discuss how the implementation of the Affordable Care Act (ACA) is affecting people with diabetes at the Endocrine Society’s policy summit.
The summit, which will take place on September 12, will delve into ways to maximize the benefits and overcome unforeseen challenges the new law poses for people with diabetes.
This summit will explore:
• Current challenges to treating and preventing diabetes.
• The cost of diabetes care and the impact on various stakeholder groups, including people with diabetes, insurers and health care providers.
• Intended benefits of the ACA and how this shift in health care policy may affect diabetes care and outcomes.
Friday, September 12, 2014
9 a.m. – 4 p.m.
Ronald Reagan Building and International Trade Center - Atrium
1300 Pennsylvania Ave., NW
Washington, DC 20004
**Registration Deadline is September 8**
Media are invited to attend this event at no cost. Seating is limited. Registration and program details are posted online at http://www.endocrine.org/meetings/diabetes-policy-summit.
# # #
Founded in 1916, the Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society’s membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.